SHARE
Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.
The University of Queensland in Australia has started dosing healthy adult participants in a Phase I clinical trial of its Covid-19 vaccine candidate.
The first dose of the potential vaccine was given at Nucleus Network’s Brisbane clinic. The trial is intended to assess the safety of the candidate, along with its ability to induce immune response in healthy volunteers.
Read more: https://www.clinicaltrialsarena.com/news/queensland-covid19-vaccine-trial/
Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.
The University of Queensland in Australia has started dosing healthy adult participants in a Phase I clinical trial of its Covid-19 vaccine candidate.
The first dose of the potential vaccine was given at Nucleus Network’s Brisbane clinic. The trial is intended to assess the safety of the candidate, along with its ability to induce immune response in healthy volunteers.
Read more: https://www.clinicaltrialsarena.com/news/queensland-covid19-vaccine-trial/
No comments:
Post a Comment